MoneyWorks4Me

Hikal reports Profit after tax of Rs 509.20 Mln, in the March 2021 quarter

06 May 2021 Evaluate
A decent increase of about 40.49% in the sales to Rs. 5324.60 millions was observed for the quarter ended March 2021. The sales figure stood at Rs. 3789.90 millions during the year-ago period.The company almost doubled its revenue to Rs. 509.20 millions  from Rs. 244.70 millions in the quarter ended March 2021.Operating profit surged to 1121.30 millions from the corresponding previous quarter of 723.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202003 201903 % Var
Sales 5324.60 3789.90 40.49 17204.40 15072.60 14.14 15072.60 15896.10 -5.18
Other Income 28.70 17.30 65.90 49.80 37.00 34.59 37.00 22.60 63.72
PBIDT 1121.30 723.60 54.96 3278.10 2768.50 18.41 2768.50 3003.90 -7.84
Interest 99.70 137.00 -27.23 361.40 524.20 -31.06 524.20 584.30 -10.29
PBDT 1021.60 586.60 74.16 2916.70 2090.30 39.53 2090.30 2419.60 -13.61
Depreciation 215.50 209.40 2.91 852.40 824.60 3.37 824.60 928.80 -11.22
PBT 806.10 377.20 113.71 2064.30 1265.70 63.10 1265.70 1490.80 -15.10
TAX 296.90 132.50 124.08 732.80 421.40 73.90 421.40 460.10 -8.41
Deferred Tax -45.80 44.50 -202.92 -62.70 74.40 -184.27 74.40 5.10 1358.82
PAT 509.20 244.70 108.09 1331.50 844.30 57.70 844.30 1030.70 -18.08
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 21.06 19.09 10.30 19.05 18.37 3.73 18.37 18.90 -2.80
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..